PT98764A - Processo para a preparacao de composicoes contendo factor de desenvolvimento de insulina 1 completo para o tratamento terapeutico ou profilactico de estado catabolicos - Google Patents

Processo para a preparacao de composicoes contendo factor de desenvolvimento de insulina 1 completo para o tratamento terapeutico ou profilactico de estado catabolicos

Info

Publication number
PT98764A
PT98764A PT98764A PT9876491A PT98764A PT 98764 A PT98764 A PT 98764A PT 98764 A PT98764 A PT 98764A PT 9876491 A PT9876491 A PT 9876491A PT 98764 A PT98764 A PT 98764A
Authority
PT
Portugal
Prior art keywords
therapeutic
complete
cataractic
compositions
development
Prior art date
Application number
PT98764A
Other languages
English (en)
Other versions
PT98764B (pt
Inventor
Peter Gluckman
Linda Fryklund
Anna Skottner
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20380208&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT98764(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of PT98764A publication Critical patent/PT98764A/pt
Publication of PT98764B publication Critical patent/PT98764B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PT98764A 1990-08-24 1991-08-23 Processo para a preparacao de composicoes contendo factor de desenvolvimento de insulina 1 completo para o tratamento terapeutico ou profilactico de estado catabolicos PT98764B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002731A SE9002731D0 (sv) 1990-08-24 1990-08-24 Product comprising growth factor

Publications (2)

Publication Number Publication Date
PT98764A true PT98764A (pt) 1993-09-30
PT98764B PT98764B (pt) 1999-01-29

Family

ID=20380208

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98764A PT98764B (pt) 1990-08-24 1991-08-23 Processo para a preparacao de composicoes contendo factor de desenvolvimento de insulina 1 completo para o tratamento terapeutico ou profilactico de estado catabolicos

Country Status (14)

Country Link
US (1) US6034059A (pt)
EP (1) EP0546007B2 (pt)
JP (1) JP2521867B2 (pt)
AT (1) ATE147988T1 (pt)
AU (1) AU650050B2 (pt)
CA (1) CA2088674A1 (pt)
DE (1) DE69124382T3 (pt)
DK (1) DK0546007T3 (pt)
ES (1) ES2097816T5 (pt)
GR (1) GR3022935T3 (pt)
IE (1) IE912615A1 (pt)
PT (1) PT98764B (pt)
SE (1) SE9002731D0 (pt)
WO (1) WO1992003154A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402331D0 (sv) * 1994-07-01 1994-07-01 Pharmacia Ab New use
US6335317B1 (en) 1998-04-10 2002-01-01 Emory University Use of gut-trophic growth factors to improve oxidative status
EP1402266B1 (en) 2000-11-28 2011-01-12 Premacure AB Reducing RISK OF COMPLICATIONS OF PREMATURITY
JP3896879B2 (ja) * 2002-03-22 2007-03-22 日本電気株式会社 トラヒック監視システム
ES2532089T3 (es) * 2005-06-02 2015-03-24 Ipsen Biopharmaceuticals, Inc. GH e IGF-1 para el tratamiento de trastornos del crecimiento

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0720993B2 (ja) * 1985-08-22 1995-03-08 グロペップ プロプライエタリー リミテッド 生長因子
US4963665A (en) * 1986-01-07 1990-10-16 Washington University Human preproinsulin-like growth factor I
JP2573976B2 (ja) * 1986-01-09 1997-01-22 ブリガム・アンド・ウイメンズ・ホスピタル 低カロリ−状態での窒素保持のための成長ホルモンの使用
ATE82506T1 (de) * 1987-08-21 1992-12-15 Imcera Group Inc Stabilisierung von wachstumshormonen.
EP0346429B1 (en) * 1987-12-24 1994-12-28 Gropep Pty. Ltd. Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2)

Also Published As

Publication number Publication date
ATE147988T1 (de) 1997-02-15
GR3022935T3 (en) 1997-06-30
EP0546007A1 (en) 1993-06-16
PT98764B (pt) 1999-01-29
IE912615A1 (en) 1992-02-26
ES2097816T5 (es) 2003-07-16
AU8448891A (en) 1992-03-17
DK0546007T3 (da) 1997-03-17
WO1992003154A1 (en) 1992-03-05
JP2521867B2 (ja) 1996-08-07
US6034059A (en) 2000-03-07
AU650050B2 (en) 1994-06-09
DE69124382T3 (de) 2003-09-11
EP0546007B2 (en) 2003-01-29
CA2088674A1 (en) 1992-02-25
SE9002731D0 (sv) 1990-08-24
ES2097816T3 (es) 1997-04-16
EP0546007B1 (en) 1997-01-22
DE69124382T2 (de) 1997-06-26
JPH05509323A (ja) 1993-12-22
DE69124382D1 (de) 1997-03-06

Similar Documents

Publication Publication Date Title
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
DE68919358D1 (de) Zusammensetzung zur behandlung der schizophrenie.
DK155143C (da) Antioestrogent laegemiddel til behandling af benigne og canceroese tilstande i brystet
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
ATE139447T1 (de) Mittel zur verstaerkung der wirkung von antitumoralen mittel und zur widerstandsbekaempfung von vielfachdrogen
BR9813373A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente
BR9006924A (pt) Formulacao para tratamento de sintomas e doencas,uso de formulacao para o tratamento de sintomas e doencas,metodo para o tratamento de sintomas e doencas,distribuicao de agentes medicinais e terapeuticos para o tratamento de sintomas e doencas e combinacao para administracao em mamiferos
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
MY132626A (en) CARBAZOLYL-SUBSTITUTED ETHANOLAMINES AS SELECTIVE ß-3 AGONISTS
SE9404196D0 (sv) New antithrombotic formulation
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
FI952985A0 (fi) Kuumeenhoito- ja puudutusmenetelmiä ja optisesti puhdasta R-ketorolakkia sisältäviä koostumuksia
FI971951A0 (fi) 2,2-dikloroalkaanikarboksyylihapot, menetelmät niiden valmistamiseksi, niitä sisältävät lääkkeet, ja niiden käyttö insuliiniresistanssin hoitoon
ATE287710T1 (de) Verfahren zum modulieren der mikrozirkulation
IL81573A (en) Pharmaceutical preparations for the treatment of psoriasis containing tamoxifen
DE69800859D1 (de) Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
PT98764A (pt) Processo para a preparacao de composicoes contendo factor de desenvolvimento de insulina 1 completo para o tratamento terapeutico ou profilactico de estado catabolicos
ATE64300T1 (de) Wirkstoffe zur anwendung bei der behandlung von tumoren.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
DE58903659D1 (de) Pharmazeutische zubereitung zur behandlung entzuendeter nasenschleimhaeute.
HUT70521A (en) Process to prepare pharmaceutical comps. again amyloidosis
AU2824289A (en) Thienotricyclene for the treatment of bronchial diseases
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
DE3776662D1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
UA40974A (uk) Спосіб лікування міопії у дітей та підлітків

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930507

FG3A Patent granted, date of granting

Effective date: 19981027

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20000430